2018, Número 2
<< Anterior Siguiente >>
Dermatología Cosmética, Médica y Quirúrgica 2018; 16 (2)
Púrpura fulminante neonatal: un caso y revisión de la literatura
González CAC, Corral CJC, González MTN, Vega MME
Idioma: Español
Referencias bibliográficas: 22
Paginas: 145-149
Archivo PDF: 156.01 Kb.
RESUMEN
La púrpura fulminante neonatal es una enfermedad grave y
poco frecuente, causada por deficiencias congénitas o adquiridas
de las proteínas C o S. Tiene alta mortalidad a menos que
se realice el diagnóstico temprano y se inicie tratamiento. Describimos
el caso de un recién nacido que comenzó de manera
súbita, secundario a un infección intrahospitalaria por
Acinetobacter
junii, una dermatosis caracterizada por ampollas tensas,
de contenido seroso y hemático, con evolución posterior a necrosis.
Se documentó una deficiencia de proteína C transitoria.
Recibió tratamiento con antibióticos, plasma fresco congelado
y anticoagulación, con lo cual se recuperó totalmente.
REFERENCIAS (EN ESTE ARTÍCULO)
Dabiri G, Damstetter E, Chang Y, Ebot B, Gloeckner J y Phillips T, Coagulation disorders and their cutaneous presentations: diagnostic work-up and treatment, J Am Acad Dermatol 2016; 74:795-804.
Bacciedonia V, Attiec M y Donatod H, Thrombosis in newborn infants, Arch Argent Pediatr 2016; 114:159-66.
Konda S, Zell D, Milikowski C y Llamazares JA, Purpura fulminans associated with Streptococcus pneumoniae septicemia in an asplenic pediatric patient, Actas Dermosifiliogr 2013; 104:623-7.
Price VE, Ledingham D, Krümpel A y Chan A, Diagnosis and management of neonatal purpura fulminans, Semin Fetal Neonatal Med 2011; 16:318.
Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A, Morgan M y Mumford AD, Purpura fulminans: recognition, diagnosis and management, Arch Dis Child 2011; 96:1066-71.
Goldenberg N y Manco-Johnson M, Protein C deficiency, Haemophilia 2008; 14:1214-21.
Warner PM et al., Current management of purpura fulminans: a multicenter study, J Burn Care Rehabil 2003; 24:119-26.
Sen K y Roy A, Management of neonatal purpura fulminans with severe protein C deficiency, Indian Pediatrics 2006; 43:542-5.
Van Der Horst R, Purpura fulminans in a newborn baby, Arch Dis Child 1982; 37:426-41.
Seligsohn U y Lubetsky A, Genetic suceptibility to venous thrombosis, N Engl J Med 2001; 344:1222-31.
Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B y Casey W, Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans, Lancet 1997; 350:1590.
Fourrier F, Lestavel P, Chopin C, Marey A, Goudemand J, Rime A y Mangalaboyi J, Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates, Intensive Care Med 1990; 16:121.
Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A y Rapaport SI, Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn, N Engl J Med 1984; 310:559.
Marciniak E, Wilson HD y Marlar RA, Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood, Blood 1985; 65:15.
Peters C, Casella JF, Marlar RA, Montgomery RR y Zinkham WH, Homozygous protein C deficiency: observations on the nature of the molecular abnormality and the effectiveness of warfarin therapy, Pediatrics 1988; 81:272.
Sugahara Y, Miura O, Yuen P y Aoki N, Protein C deficiency Hong Kong 1 and 2: hereditary protein C deficiency caused by two mutant alleles, a 5-nucleotide deletion and a missense mutation, Blood 1992; 80:126.
Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ y Hathaway WE, Neonatal purpura fulminans associated with homozygous protein S deficiency, Lancet 1990; 335:61-2.
Pung-Amritt P, Poort SR, Vos HL, Bertha RM, Mahasandana C, Tanphaichitr VS et al., Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency, Thromb Haemost 1999; 81:189.
Jalbert LR, Rosen ED, Moons L, Chan JC, Carmeliet P, Collen D et al., Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice, J Clin Invest 1998; 102:1481.
Yuen P, Cheung A, Lin HJ, Ho F, Mimuro J, Yoshida N et al., Purpura fulminans in a Chinese boy with congenital protein C deficiency, Pediatrics 1986; 77:670.
Vigano D’Angelo S, Comp PC, Esmon CT y D’Angelo A, Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states, J Clin Invest 1986; 77:416.
Viganò S et al., Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy, Br J Haematol 1984; 57:213.